Longevity Clinic Outcomes and Follow-Up Scorecard (2026)

A longevity clinic outcomes and follow-up scorecard is the simplest way to tell whether a premium assessment is serious preventive medicine or just an expensive snapshot.

Most longevity clinics are good at the first visit: full-body imaging, blood panels, DEXA, VO2 max, genomics, biological-age testing, wearables, AI dashboards, and a polished report. The harder question comes later: what changed after the data arrived?

The sector is starting to face that question. A 2026 Milan Longevity Summit panel, reported by Longevity.Technology, framed the next stage around standards, longitudinal data, clinical judgment, interoperability, and continuity of care rather than diagnostics alone.¹ A peer-reviewed framework for healthy longevity clinics reaches a similar conclusion: there is not yet one universal clinic model, so measurement standards, biomarkers, wearable data, and medical governance matter.²

For buyers using the WLC ranking, clinic comparison tool, or Find Your Clinic, this scorecard extends our guides to post-assessment follow-up and clinic standards. Do not judge a clinic only by what it measures. Judge it by what it does next.

Medical note: this is a buyer-education guide, not personal medical advice. Follow-up should be individualized by a qualified clinician based on age, sex, symptoms, family history, medication use, risk profile, country, and prior results.

Urgent-care note: do not wait for a clinic portal response for severe symptoms, chest pain, neurologic symptoms, critical lab calls, clinician-marked urgent imaging findings, or anything your local clinician treats as urgent. Seek local medical care.

Benchmarked against: this scorecard was checked against clinical sources on prevention, imaging, DEXA, blood pressure, sleep, biological-age testing, and AI-enabled devices, plus commercial pages from Human Longevity Inc., Biograph, Fountain Life, and Princeton Longevity Center.^{1234567891011} The goal is to test whether the buyer questions match the claims serious programs already make.

What should a good longevity clinic follow-up plan look like?

A credible follow-up loop should answer these questions in writing:

• Who is the named medical owner after the assessment?
• Which findings are urgent, important, optional, or exploratory?
• What should change in the first 30 days?
• Which markers should be retested at 90 days, 6 months, or 12 months?
• Which tests should not be repeated unless a decision depends on them?
• What triggers referral to primary care, cardiology, radiology, endocrinology, neurology, sleep medicine, genetics, or another specialist?
• How are records exported so your regular doctor can use them?

That is the difference between a health-data product and a care pathway. A clinic can measure 100 biomarkers and still fail if no one owns interpretation.

Use the scorecard before paying a deposit, especially if the package includes broad imaging, AI diagnostics, biological-age testing, wearables, supplements, hormones, peptides, or regenerative therapies.

The longevity clinic outcomes scorecard

Scorecard domain	What good looks like	Meaningful endpoint	Red flag	Buyer question
Baseline assessment	History, medications, family risk, labs, function, imaging only when justified	Clear priority list, not just test volume	Package starts with treatments before risk review	”What finding would change my plan?”
Doctor-owned review	Licensed clinician signs the interpretation and escalation plan	Named medical owner for abnormal results	”Our care team” with no accountable clinician	”Who calls me if something is urgent?”
Action plan	Prioritized next steps for risk reduction, referral, training, nutrition, sleep, medications, or monitoring	One-page plan with urgent, important, optional, exploratory categories	Every abnormal marker becomes an upsell	”What are the top three actions in the next 90 days?”
Repeat timing	Tests repeated only when the timing can change a decision	30/90/365-day cadence matched to finding	Annual repeat panels by default	”Why repeat this test, and what threshold changes care?”
Meaningful endpoint	Conventional clinical markers plus functional and adherence outcomes	Blood pressure, ApoB/LDL context, HbA1c, DEXA, VO2, sleep, symptoms, resolved referrals	Biological-age score treated as proof of success	”What outcome matters besides the dashboard?”
Data portability	Labs, imaging reports, plan, medication list, and referrals are exportable	Your usual doctor can act on the record	Portal-only PDF with no clinical handoff	”Can you send usable records to my doctor?”
Escalation pathway	Abnormal imaging, cognitive findings, genetics, or high cardiometabolic risk trigger clear referral rules	Timely specialty or primary-care handoff	”Ask your doctor” with no summary or urgency	”Which findings are urgent, and who coordinates them?”

The scorecard is intentionally conservative. It does not ask whether a clinic can prove longer life from a short program. It asks whether the clinic can demonstrate accountability, coherent tracking, and a reasonable chain from measurement to decision.

How to score a clinic

Use the seven domains as a quick screening tool before you book:

• 0 points if the clinic does not answer the domain clearly;
• 1 point if it gives a partial answer, but the owner, timing, endpoint, or escalation rule is vague;
• 2 points if the clinic gives a written, specific answer that a regular doctor could understand.

A score of 0-6 suggests a weak follow-up loop. A score of 7-10 is mixed: ask for details before paying. A score of 11-14 is stronger, but it is still not a medical certification, proof of outcomes, or guarantee that the clinic is right for your case.

What should be tracked by domain?

The best follow-up plans separate conventional clinical markers from exploratory longevity metrics. That protects the patient from both under-treatment and over-treatment.

Cardiometabolic markers

Cardiometabolic follow-up is often the highest-yield part of a longevity program. Blood pressure, cholesterol context, ApoB or LDL-C, Lp(a), triglycerides, glucose, HbA1c, kidney and liver markers, smoking status, family history, waist measures, sleep apnea risk, and medication review can change real medical decisions.

The American Heart Association emphasizes knowing cholesterol levels and understanding treatment because excess LDL or non-HDL cholesterol contributes to atherosclerotic cardiovascular disease risk.³ USPSTF recommendation topics are also a useful anchor for evidence-based preventive-service thinking: clinics should justify routine follow-up by decision value, not by how many optional tests a dashboard can display.⁴

Good follow-up question: What should change in the next 90 days if ApoB, LDL-C, blood pressure, glucose, or HbA1c is abnormal?

Body composition and DEXA

DEXA, when used well, links bone density, lean mass, fat distribution, and training priorities. RadiologyInfo describes DXA as the established standard for measuring bone mineral density and a common tool for diagnosing osteoporosis and assessing fracture risk.¹² A serious plan connects it to training, protein adequacy, fall risk, metabolic risk, and a retest interval that can change decisions.

Useful endpoint: lean-mass preservation, visceral-fat reduction where relevant, bone-density follow-up when indicated, and a training plan that can be followed outside the clinic.

VO2 max, strength, and functional fitness

Fitness is one of the more evidence-backed healthspan domains. In a large JAMA Network Open cohort, cardiorespiratory fitness was inversely associated with long-term mortality among adults undergoing treadmill testing.¹³ That does not mean a clinic can promise lifespan extension because it measures VO2 max. It does mean a low fitness result should lead to a structured training plan, safety screening where needed, and a retest window.

Useful endpoint: training zones, strength priorities, functional capacity, and repeat testing only after enough time has passed for adaptation.

Blood pressure, sleep, and recovery

Blood pressure should not be buried inside a dashboard. AHA categories separate elevated, hypertensive, and urgent readings, while the CDC notes that regular measurement and home monitoring can help care teams diagnose and control problems early.¹⁴¹⁵ If pressure is elevated, the plan should state whether confirmation, home monitoring, medication review, primary-care follow-up, sleep apnea evaluation, or cardiovascular risk management is needed.

Sleep follow-up should also be practical: sleep duration, suspected apnea, daytime fatigue, alcohol, medications, mood, shift work, and wearable trends can matter. NHLBI notes that sleep apnea can involve repeated breathing interruptions and may require a sleep study.¹⁶ Wearables can track patterns, but they should not replace clinical evaluation when risk is high.

Cognitive and brain-health testing

Cognitive screening, brain-health assessments, and neurologic dashboards need a careful handoff. A National Academies review hosted by NCBI Bookshelf notes that cognitive aging is intertwined with medical conditions, medications that affect cognition, sleep disruption, blood pressure, inflammation, heart disease, and physical activity.¹⁷ A clinic should not treat an abnormal cognitive score as a nootropic-sales event.

Useful endpoint: documented referral or follow-up when cognitive, sleep, medication, mood, hearing, vascular, or neurologic concerns appear.

Imaging findings

Imaging creates the biggest follow-up burden. Full-body MRI, coronary CT, brain MRI, lung CT, carotid ultrasound, DEXA, and emerging scanner concepts can be useful in selected contexts. They can also create incidental findings, anxiety, repeat imaging, biopsies, specialist visits, and cost.

The American College of Radiology states that it does not believe there is sufficient evidence to recommend total-body screening for asymptomatic people with no risk factors or family history suggesting disease, and it warns that nonspecific findings can lead to unnecessary testing, procedures, and expense.⁵

Useful endpoint: radiology report, urgency category, named clinician, referral pathway, repeat-imaging interval, and records transfer.

Epigenetic and biological-age tests

Biological-age tests can be interesting context, especially when measured consistently over time. They should not be the main proof of success. Reviews of epigenetic clocks describe real promise but also substantial challenges around robustness, context-specific models, and practical interpretation.⁶

Useful endpoint: the clinic can explain the assay, lab, model, test-retest variability, what change exceeds noise, and what clinical decision changes if the score moves. If a lower biological-age number is used to sell IVs, peptides, supplements, or “reversal” claims, step back.

Wearables, dashboards, and AI

Wearables and AI dashboards are useful only when they support human review. The FDA’s public list of AI-enabled medical devices shows how specific regulated AI tends to be: tool, specialty, date, and intended context, not a general claim to “optimize longevity.”⁷

Useful endpoint: the clinic names each AI tool, states whether it is regulated or internally validated, defines review thresholds, and explains who responds when a wearable or dashboard signal is concerning.

For deeper context, read our guides to AI diagnostics, biological-age testing technologies, and full-body MRI false positives.

A practical 30/90/365-day follow-up model

The exact cadence depends on the person and the finding. But a serious clinic should be able to explain a model like this:

Timing	What should happen	Examples of appropriate follow-up	What should not happen
First 7 days	Result triage and urgent handoff	Suspicious imaging, very high blood pressure, serious lab abnormalities, concerning symptoms, medication safety issues	Patient left with a report and no named owner
30 days	Action plan is active	Referral scheduled, home BP started, training plan begins, sleep study ordered, medication review completed	New treatment bundle sold before interpretation
90 days	High-leverage markers reviewed	BP trend, lipids or glucose when clinically appropriate, adherence, training response, symptoms, sleep plan	Repeating every biomarker because the dashboard allows it
6 to 12 months	Meaningful reassessment	DEXA or VO2 retest when enough time has passed, annual imaging only if justified, updated risk plan	Biological-age score used as the main renewal proof
Annual renewal	Decide whether the program earned renewal	Did care change? Were abnormalities resolved? Did records transfer? Were risks reduced?	Membership renews automatically without outcomes review

This is also where clinic model matters. Human Longevity Inc. and Biograph are diagnostic-forward models where the buyer should ask how physician review, referrals, and repeat testing work after the initial assessment.⁸⁹ Fountain Life is closer to an annual membership model, so the question becomes which diagnostics, therapies, and follow-up touchpoints are included by tier.¹⁰ Princeton Longevity Center sits closer to executive preventive medicine and follow-up coaching.¹¹ Progevita belongs in a European residential comparison: the key question is whether the stay produces a portable plan that can continue after the patient returns home.

The best fit depends on whether you need a dense diagnostic baseline, annual monitoring, a hospital-style executive physical, a residential reset, or concierge preventive medicine.

Red flags after a longevity clinic assessment

Be cautious when a clinic:

• gives you a result dashboard without physician interpretation;
• repeats biological-age tests as proof of “reversal”;
• bundles treatments before diagnosis or risk review;
• sells supplements, IVs, peptides, or hormone protocols from weak signals;
• cannot explain which findings trigger referral;
• cannot export records to your usual doctor;
• treats broad imaging as universally beneficial;
• makes AI outputs sound like diagnoses;
• has no written owner for abnormal-result follow-up;
• cannot explain what would make the program not worth renewing.

The red flag is not advanced testing. The red flag is advanced testing without medical accountability.

Buyer checklist before paying

Ask before booking or renewing:

1. Can you show me a sample follow-up plan?
2. Who signs the final interpretation?
3. What is included at 30, 90, and 365 days?
4. What findings trigger urgent contact?
5. What findings trigger referral to outside specialists?
6. Which tests are repeated only when clinically useful?
7. Which metrics are exploratory?
8. What records can I export?
9. Can my primary doctor receive a concise clinical summary?
10. What outcome would make renewal worthwhile?

If the clinic answers clearly, it may be building a real preventive-care loop. If the answers stay vague, compare alternatives before paying. The best longevity clinics guide and WLC’s ranking reward transparent diagnostics, realistic evidence language, physician-led interpretation, and follow-up because those are not cosmetic details. They are the product.

How should clinic models be compared?

Clinic model	Best use case	Follow-up strength to verify	Weakness to watch
Diagnostic membership	Dense testing plus longitudinal monitoring	Named care team, repeat timing, abnormal-result accountability	Dashboard renewal without decision-changing outcomes
Hospital executive health	Conventional preventive medicine and specialist access	Records, referrals, and clear post-exam plan	Less longevity-specific coaching or biomarker tracking
Residential longevity resort	Behavior change, recovery, structured environment	Post-stay handoff and home continuation plan	Strong experience but weak medical continuity
Concierge preventive medicine	Ongoing physician relationship	Medication review, risk management, coordination	May lack advanced diagnostics or transparent pricing

The right question is not “which model is most advanced?” It is “which model will still be useful after the first report?”

Bottom line

A longevity clinic is only as credible as its follow-up loop: baseline data, named medical accountability, measurable endpoints, repeat testing only when useful, and a clear escalation plan for abnormal findings.

The best programs do not promise that a dashboard will reverse aging. They show what they know, what they will monitor, what they will escalate, and how the patient can keep the plan alive after leaving the clinic.

Before you buy a longevity assessment, ask for the follow-up scorecard. If the clinic cannot produce one, you may be buying data without accountability.

FAQ: Longevity clinic outcomes and follow-up

What should a longevity clinic follow-up plan include?

It should name the responsible clinician, separate urgent from exploratory findings, define 30- and 90-day actions, specify 6- to 12-month retests, and explain referral pathways.

How do you measure longevity clinic outcomes?

Use conventional clinical markers, functional markers, adherence markers, and documented resolution of abnormal findings: blood pressure, lipids or glucose when indicated, VO2 or strength, sleep-plan adherence, DEXA over a realistic interval, completed referrals, and records transfer.

Are biological-age tests good follow-up outcomes?

They are weak primary outcomes. They can be exploratory trend markers, but not proof of disease prevention, longer life, or aging reversal. A clinic should explain what clinical decision changes if the score moves.

What should happen after abnormal imaging?

The clinic should provide a radiology report, classify urgency, name the responsible clinician, recommend referral or monitoring, transfer records, and clarify repeat-imaging costs.

Are annual longevity memberships worth it?

They can be worth it if repeated diagnostics, physician interpretation, care-team access, and follow-up change decisions. They are weaker if the main renewal argument is a refreshed dashboard.

What is the biggest follow-up red flag?

The biggest red flag is a beautiful report with no named clinician, no escalation plan, no data export, and no explanation of useful retests.

Sources

Footnotes

1. Longevity.Technology, Longevity clinics face their proving ground. ↩ ↩²

2. Bensz J, et al. A Framework for an Effective Healthy Longevity Clinic. Aging and Disease. ↩ ↩²

3. American Heart Association, Prevention and Treatment of High Cholesterol. ↩ ↩²

4. U.S. Preventive Services Task Force, Recommendation Topics. ↩ ↩²

5. American College of Radiology, ACR Statement on Screening Total Body MRI. ↩ ↩²

6. Epigenetic Clocks: Beyond Biological Age, Using the Past to Predict the Present and Future. ↩ ↩²

7. FDA, Artificial Intelligence-Enabled Medical Devices. ↩ ↩²

8. Human Longevity Inc., Executive Health Assessment. ↩ ↩²

9. Biograph, How Biograph Works and Memberships. ↩ ↩²

10. Fountain Life, Memberships and APEX Longevity Membership. ↩ ↩²

11. Princeton Longevity Center, The Future of Preventive Medicine and Follow-Up Programs. ↩ ↩²

12. RadiologyInfo, Bone Density Scan (DEXA or DXA). ↩

13. Mandsager K, et al. Association of Cardiorespiratory Fitness With Long-term Mortality Among Adults Undergoing Exercise Treadmill Testing. JAMA Network Open. 2018. ↩

14. American Heart Association, Understanding Blood Pressure Readings. ↩

15. CDC, Measuring Your Blood Pressure. ↩

16. National Heart, Lung, and Blood Institute, Sleep Apnea. ↩

17. National Academies Press via NCBI Bookshelf, Risk and Protective Factors and Interventions: Lifestyle and Physical Environment. ↩